Loading…
ResMed Inc. is projected to rise to $237.95 by 2027, a +16% move from its current price of $205.09. RMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $200.97 | $205.15 | $209.41 | +0.03% |
| Jul 13 | $199.32 | $205.21 | $211.26 | +0.06% |
| Jul 14 | $198.08 | $205.26 | $212.71 | +0.08% |
| Jul 15 | $197.04 | $205.32 | $213.94 | +0.11% |
| Jul 16 | $196.14 | $205.38 | $215.05 | +0.14% |
| Jul 17 | $195.34 | $205.43 | $216.05 | +0.17% |
| Jul 18 | $194.60 | $205.49 | $216.99 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $194.60 | $205.49 | $216.99 | +0.19% |
| Week 2 | $190.63 | $205.89 | $222.36 | +0.39% |
| Week 3 | $187.73 | $206.29 | $226.68 | +0.58% |
| Week 4 | $185.37 | $206.69 | $230.46 | +0.78% |
| Week 5 | $183.35 | $207.09 | $233.89 | +0.97% |
| Week 6 | $181.59 | $207.49 | $237.08 | +1.17% |
| Week 7 | $180.00 | $207.89 | $240.09 | +1.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software.
ResMed was founded in 1989 and is headquartered in San Diego, California.
Its sleep and home diagnostics portfolio includes ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also offers AirView, a cloud-based system for remote monitoring and changing of patient device settings; myAir, a personalized therapy management application for patients with sleep apnea; and a connectivity module providing a cellular connection between compatible ventilation devices and the AirView system. In addition, the company provides Brightree solutions for home medical equipment and related services, HEALTHCAREfirst for electronic health records and related services, MatrixCare EHR software as a service for long-term care providers, and MEDIFOX DAN software for residential care providers.
ResMed is categorized in Healthcare and operates globally with the goal of diagnosing, treating, and managing respiratory disorders through its devices and software offerings.
ResMed Inc. (RMD) is a healthcare company with a current price of $218.40 and a market capitalization of $31.68B, ranking 431 by market position. The stock sits within a broad forecast that starts at 2026 with an average price equal to $218.40, a low of $182.82, and a high of $288.20, and a 0% ROI with neutral sentiment for that year.
Looking further out, the forecast projects a bullish multi-year path, with 2030 averaging $302.38 and a 38.5% ROI, 2040 averaging $778.50 and a 256.5% ROI, and 2050 averaging $1,287.87 and a 489.7% ROI. These figures imply meaningful upside over the longer horizon, though they remain estimates rather than guarantees.
Current price and near-term data are complemented by a longer-term outlook that envisions substantial growth, contingent on market dynamics and other factors.
A major floor 19.4% below — a decisive break under it would weaken the trend.
The nearest floor, 10.9% below — buyers have tended to step in here.
The nearest ceiling, 7.1% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key RMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $211.26 | Sell | $207.44 | Sell |
| MA 10 | $206.06 | Sell | $205.68 | Sell |
| MA 20 | $199.21 | Buy | $202.55 | Buy |
| MA 50 | $200.83 | Buy | $204.91 | Buy |
| MA 100 | $218.28 | Sell | $215.43 | Sell |
| MA 200 | $237.59 | Sell | $228.28 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.62 | Neutral |
| Stoch RSI (14) | 41.88 | Neutral |
| CCI (20) | 42.18 | Neutral |
| Williams %R (14) | -50.73 | Info |
| MACD (12,26,9) | 1.59 | Buy |
| ROC (12) | 6.59 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 49.27 | Neutral |
| TRIX (15) | 0.08 | Buy |
| Awesome (5,34) | 13.05 | Buy |
| Ultimate (7,14,28) | 59.88 | Neutral |
| Momentum (10) | 5.27 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 210.14 | Sell |
| ADX (14) | 17.52 | Neutral |
| ATR (14) | 4.36 | Info |
The 30-day technical picture shows bullish sentiment with RSI14 at 70. The near-term price action is supported by a base at $182.82 and resistance at $218.40, with a 30-day trading range from $192.53 to $247.74.
The stock is trading around key moving averages, with SMA50 at $201.64 and SMA200 at $238.86, indicating a mix of short-term momentum and longer-term resistance. These technical levels help define the immediate support and resistance envelope as the stock fluctuates within the 30-day window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $182.82 | $205.09 | $270.64 | 0% | Neutral | |
| $193.76 | $237.95 | $306.33 | +16% | Neutral | |
| $207.89 | $260.59 | $345.28 | +27% | Bullish | |
| $210.07 | $267.79 | $362.99 | +31% | Bullish | |
| $208.92 | $270.28 | $373.49 | +32% | Bullish | |
| $239.09 | $313.50 | $440.58 | +53% | Bullish | |
| $264.76 | $351.48 | $501.52 | +71% | Bullish | |
| $287.34 | $385.92 | $558.32 | +88% | Bullish | |
| $317.15 | $430.65 | $631.01 | +110% | Bullish | |
| $315.63 | $433.08 | $642.16 | +111% | Bullish | |
| $459.38 | $660.56 | $1,029.79 | +222% | Bullish | |
| $691.71 | $1,075.69 | $1,805.82 | +424% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $182.82 | $205.09 | $249.16 | +0.00% |
| August 2026 | $180.51 | $211.68 | $253.91 | +3.21% |
| September 2026 | $178.42 | $210.33 | $254.42 | -0.64% |
| October 2026 | $181.79 | $215.26 | $262.24 | +2.34% |
| November 2026 | $185.35 | $220.31 | $270.00 | +2.35% |
| December 2026 | $184.12 | $219.62 | $270.64 | -0.31% |
Click any year to see its month-by-month RMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RMD is projected to trade between $182.82 and $270.64, averaging $205.09 — a potential gain of 0% from today's $205.09. Price action looks broadly range-bound.
ResMed Inc.'s 2027 outlook centres on $237.95, within a $193.76 to $306.33 range. That is up +16% on the projected 2026 average. That marks a +16% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, RMD could reach as high as $345.28, with a base case around $260.59 and support toward $207.89 — roughly +27% from $205.09. Momentum favours further upside here.
Expect RMD to range from $210.07 to $362.99 through 2029. The $267.79 average target implies a +31% move from current prices. That is up +3% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The RMD price prediction for 2030 points to an average of $270.28 (low $208.92, high $373.49) — a potential gain of +32% on today's $205.09. Momentum favours further upside here.
In 2031, RMD is projected to trade between $239.09 and $440.58, averaging $313.50 — a potential gain of +53% from today's $205.09. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
ResMed Inc.'s 2032 outlook centres on $351.48, within a $264.76 to $501.52 range. That is up +12% on the projected 2031 average. That marks a +71% change versus current levels. Momentum favours further upside here.
By 2033, RMD could reach as high as $558.32, with a base case around $385.92 and support toward $287.34 — roughly +88% from $205.09. Buyers look set to stay in control over this stretch.
Expect RMD to range from $317.15 to $631.01 through 2034. The $430.65 average target implies a +110% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The RMD price prediction for 2035 points to an average of $433.08 (low $315.63, high $642.16) — a potential gain of +111% on today's $205.09. Buyers look set to stay in control over this stretch.
In 2040, RMD is projected to trade between $459.38 and $1,029.79, averaging $660.56 — a potential gain of +222% from today's $205.09. That is up +53% on the projected 2035 average. Momentum favours further upside here.
ResMed Inc.'s 2050 outlook centres on $1,075.69, within a $691.71 to $1,805.82 range. That is up +63% on the projected 2040 average. That marks a +424% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in RMD today (≈ 4.875849 RMD) could be worth
$5,244.9
+$4,244.9 (+424%) by 2050 · US Dollar
Based on the average projected RMD price of $1,075.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RMDwould be worth at today's price.
$1,000 invested in RMD on Jul 10, 2025 (≈ 3.874918 RMD) would be worth
$794.72
-$205.28 (-20.5%) today · 0.79× · US Dollar
Based on a RMD entry price of $258.07 vs. today's $205.09.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $209.63 | $978.35 | -2.2% |
| 1 month ago | $193.57 | $1,059.53 | +6.0% |
| 3 months ago | $228.87 | $896.11 | -10.4% |
| 6 months ago | $257.84 | $795.43 | -20.5% |
| 1 year ago | $258.07 | $794.72 | -20.5% |
| All time (5.0y) ago | $248.84 | $824.19 | -17.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RMD forecast.
Our base-case forecast reaches $410.00 around 2034.
Implied market cap at $410.00: $59.47B
The multi-year forecast outlines a bullish path at key milestones. In 2030, the average price is projected at $302.38 with a 38.5% ROI, supported by a bullish sentiment. By 2040, the average rises to $778.50 with a 256.5% ROI, and by 2050 the average is $1,287.87 with a 489.7% ROI, all bearing a bullish outlook.
These figures illustrate a potential expansion in price well above the current level, but they are estimates and not guarantees. The forecasted path reflects sustained upside potential while acknowledging uncertainty and the possibility of deviation from these targets over time.
Tap a question to reveal the answer.
The forecast shows an avg of $302.38, a min of $235.76, a max of $413.18, and an ROI of 38.5%, with sentiment BULLISH.
Forecasts project a bullish path beyond 2030, with 2031 avg $354.19 (ROI 62.2), 2040 avg $778.50 (ROI 256.5), and 2050 avg $1,287.87 (ROI 489.7). Current price is $218.40, and forecasts are estimates, not guarantees.
Yes. The 2032 forecast max is $564.41, which exceeds $500.
Current price is $218.40 and market cap is $31.68B.
For 2026, min $182.82, avg $218.40, max $288.20, ROI 0, sentiment NEUTRAL.
ResMed Inc. Community Discussion
0Share your ResMed Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.